Portfolio Lab

Globe Life Inc.

  • Stock
  • Ticker GL
  • ISIN US37959E1029
  • NYSE

Financials · Insurance · USA

$151.65 −1.26%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Globe Life Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

GLGlobal equities (VT)

$10,000 grew to $23,390. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −61.6% in 04/2024, measured from the peak in 02/2024. It took 12 months to get back to the old peak.

1-year return
+17.3%
5-year return p.a.
+11.3%
10-year return p.a.
+8.9%
Volatility p.a.
23.7%
Largest decline
−61.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue1,4661,4801,4811,5131,5201,5601,6001,596
Net income255255253388266271288361
Earnings per share3.013.013.054.733.303.393.654.62
Balance sheet
Total assets29,07629,70529,80930,52830,81430,96631,56330,570
Liabilities23,77124,28024,39024,83924,83924,88125,40723,952
Equity5,3065,4255,4195,6895,9756,0856,1566,618
Cash165232239303145255257258
Long-term debt2,3242,3252,3262,3202,3212,3222,6652,668
Cash flow
Operating cash flow337432308306351421314326
Capital expenditure-15-12-13-97-21-25-16-15
Free cash flow322420295209330396298311

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2019 at +42.3%, weakest 2018 at −17.2%. 5 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
4 Nov 2026$4.62
5 Aug 2026$3.65
7 May 2026$3.39
25 Feb 2026$3.30
5 Nov 2025$4.73
6 Aug 2025$3.05
7 May 2025$3.01
26 Feb 2025$3.01
6 Nov 2024$3.44
7 Aug 2024$2.83
8 May 2024$2.67
28 Feb 2024$2.88

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€10bn
Market cap in trading currency
$11.4bn
Enterprise value
–
P/E
10.1
P/S
1.82
P/B
1.73
EV/Sales
–
EV/EBITDA
–
Earnings yield
9.9%
FCF yield
–

Results (last four quarters)

Revenue
$6.27bn
Gross profit
–
EBITDA
–
Net income
$1.19bn
Earnings per share
$14.96
Revenue per share
$83.18
Revenue growth
+5.5%
Earnings growth
−6.9%

Profitability

Gross margin
–
Operating margin
23.3%
Net margin
18.9%
Return on equity
19.3%
Return on assets
3.9%

Balance sheet and cash flow

Cash
$353m
Cash per share
$4.68
Financial debt
–
Debt/equity %
–
Current ratio
–
Book value per share
$87.73
Operating cash flow
–
Free cash flow
–

Dividend

Dividend yield
0.83%
Dividend (12 months)
$1.26
Yield (12 months)
0.83%
Payout ratio
8%
Ex-dividend date
5 Oct 2026

Shares and trading

Shares outstanding
75.4m
Volume
579,036
Avg. volume 3 months
501,235
Relative volume
1.1

Price and technicals

Price
$151.65
1 day
−1.3%
52-week high
$186.02
52-week low
$130.37
Distance to 52-week high
−18.5%
Distance to 52-week low
+16.3%
Distance to 50-day line
−7.6%
Distance to 200-day line
−5.9%
RSI (14)
33
Volatility 1M
35.5%

Performance

1 week
−5.7%
1 month
−10.0%
3 months
−12.4%
6 months
−3.0%
YTD
+8.4%
1 year
+16.0%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has GL performed since 11/2016?

$10,000 grew to $23,390 by 20 Nov 2026, which is +8.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is GL?

Volatility was 23.7% per year, measured on monthly returns. The largest decline from a peak was −61.6%, with the low in 04/2024.

How does GL compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, GL returned +8.9% at 23.7%. The correlation of monthly returns was 0.52; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Globe Life Inc. (GL): Return and risk | Portfolio Lab